Geftinat 250 mg Indian Gefitinib Tablets By Natco Pharma
Geftinat 250 mg manufactured by natco pharma Limited in India is the most economical brand of Gefitinib 250mg Tablets. Known for its quality standards geftinat by natco pharma is one of the highest selling brand of gefitinib tablet in India. Being the leading wholesale supplier & exporter of geftinat 250 mg tablet we offer gefitinib tablets at lowest guaranteed prices. We are supplying to all major cancer hospitals, individuals & bulk buyers.
Geftinat ( Generic Iressa 250 Gefitinib Tablets )
Brand Name: Geftinat 250 mg
Contents: Gefitinib 250 mg
manufacturers Natco Pharma Ltd
International Brand Name: Iressa
Packing: Pack of 30 tablets
Discounted Price Call +91 9013793888+91 9013793888
Geftinat 250 mg (Iressa or Gefitinib) is a cancer chemotherapy medication. GeftiNat (Iressa or Gefitinib) interferes with the growth of cancer cells and slows their growth and spread in the body. Gefitinib is used in the treatment of non-small cell lung cancer. Iressa tablets contain 250 mg of gefitinib and are available as brown film-coated tablets for daily oral administration
GeftiNat ( Gefitinib 250 mg ) is indicated as monotherapy for the continued treatment of patients with locally advanced or metastatic non-small cell lung cancer after failure of both platinum-based and docetaxel chemotherapies who are benefiting or have benefited from Gefitinib. GeftiNat (Iressa or Gefitinib) may also be used for purposes other than those listed in this drug information guide.
Gefitinib geftinat Dosage
The recommended daily dose of (Iressa or Gefitinib) is one 250 mg tablet with or without food. Higher doses do not give a better response and cause increased toxicity. However, your oncologist may make dose adjustment as per required.
Geftinat iressa 250 Side Effects
Serious side effects have been reported with the use of Alternative Iressa including: allergic reactions (difficulty breathing; closing of the throat; swelling of the lips, tongue, or face; or hives); lung problems; liver problems; eye problems; severe nausea, vomiting, loss of appetite, or diarrhea; and others.
geftinat 250 mg tablet is contraindicated in patients with severe hypersensitivity to gefitinib or to any other component of gefitinib.
It is important to know that drug should only be administered under the supervision of a qualified healthcare provider experienced in the use of cancer chemotherapeutic agents. Serious side effects like allergic reactions (difficulty breathing; closing of the throat; swelling of the lips, tongue, or face; or hives); lung problems; liver problems; eye problems; severe nausea, vomiting, loss of appetite, or diarrhea and others have been reported with the use of GeftiNat (Iressa or Gefitinib). You are advised to discuss with your doctor about the possible side effects from treatment with Gefitinib.